High-Dose Atorvastatin Raises Threshold of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention: A Randomized Controlled Study
Background. Contrast-induced nephropathy (CIN) is a significant complication of angiographic procedures resulting from injection of iodinated contrast media (CM). Patients with diabetes mellitus (DM) are at the highest risk of CIN. Statins have recently been proposed for protection against CIN due t...
Main Authors: | Ahmed Abdel-Galeel, Salma Taha, Khaled M. Elmaghraby, Ramadan Ghaleb, Amr Hanafy, Fabrizio D’Ascenzo, M. Abdelfatah Elsharef, Lobna Abdel-Wahid, Ayman Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2021-01-01
|
Series: | Journal of Interventional Cardiology |
Online Access: | http://dx.doi.org/10.1155/2021/8862316 |
Similar Items
-
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
by: Ayman Ibrahim, et al.
Published: (2020-12-01) -
Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01) -
Effects of combined use of atorvastatin and losartan in treating patients with diabetic nephropathy
by: Chao Ding, et al.
Published: (2018-10-01) -
Aortic stiffness index and its association with cardiovascular functions in children before and after transcatheter closure of PDA
by: Saud M. Elsaughier, et al.
Published: (2018-12-01) -
Correlation of corrected QT dispersion with the severity of coronary artery disease detected by SYNTAX score in non-diabetic patients with STEMI
by: Hatem Helmy, et al.
Published: (2017-06-01)